Review



human breast cancer bc cell lines mda mb 231  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC human breast cancer bc cell lines mda mb 231
    Human Breast Cancer Bc Cell Lines Mda Mb 231, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 24590 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+cancer+bc+cell+lines+mda+mb+231/MDA-MB-231/pmc12086152-71-1-13
    Average 99 stars, based on 24590 article reviews
    human breast cancer bc cell lines mda mb 231 - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Multiple Displacement Amplification:

    Article Title: Rewired glycolysis by DTL accelerates oncometabolite L-lactate generation to promote breast cancer progression
    Article Snippet: .. The human breast cancer (BC) cell lines MDA-MB-231 and CAL-51 were obtained from American Type Culture Collection (Manassas, USA) and preserved in our laboratory. .. These BC cells were cultured in DMEM/RPMI 1640 culture medium (Lonza, Switzerland) supplemented with 10% FBS (Gibco, USA), 100 units/mL penicillin, and 100 mg/mL streptomycin (Invitrogen, USA) in an incubator with 5% CO 2 at 37°C.

    Article Title: Resistin Induces LIN28A-Mediated Let-7a Repression in Breast Cancer Cells Leading to IL-6 and STAT3 Upregulation
    Article Snippet: .. The human breast cancer (BC) cell lines MDA-MB-231 and MDA-MB-468 were procured from ATCC (Manassas, VA, USA). .. Both cell lines were maintained in Dulbecco’s Modified Eagle Medium (DMEM) (GE Healthcare Life Sciences, Logan, UT, USA) in a humidified atmosphere of 5% CO 2 at 37 °C.

    Article Title: Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study
    Article Snippet: .. The human breast cancer (BC) cell lines MDA-MB-231 (Catalog No. HTB-26TM) and MCF-7 (Catalog No. CRL-3435) were purchased from American Type Culture Collection (ATCC, USA) in January 2020, and the above cells were authenticated by short tandem repeat (STR) profiling, and were tested as mycoplasma-free before our experiments. ..



    Similar Products

    human breast cancer bc cell lines mda mb 231  (ATCC)
    99
    ATCC human breast cancer bc cell lines mda mb 231
    Human Breast Cancer Bc Cell Lines Mda Mb 231, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+cancer+bc+cell+lines+mda+mb+231/MDA-MB-231/pmc12086152-71-1-13
    Average 99 stars, based on 1 article reviews
    human breast cancer bc cell lines mda mb 231 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    human breast cancer bc cell lines  (ATCC)
    99
    ATCC human breast cancer bc cell lines
    Cytotoxic function of T lymphocytes activated by SmartDC-FRα against cultured BC <t>cell</t> <t>lines</t> examined by luciferase-based assay. Expression of FRα protein in normal <t>breast-like</t> (MCF10A) and breast <t>cancer</t> (MCF-7 and MDA-MB-231) target cell lines examined by immunofluorescence staining with specific anti-FRα antibody were also depicted. Expression FRα protein indicated in green. Nuclei of the cells were stained blue color. Scale bars represent 10 µm. Percentages of specific target cell lyses of unactivated T lymphocytes (white bar), T lymphocytes activated by SmartDC-iRFP (gray bar), and T lymphocytes activated by SmartDC-FRα (black bar) after co-culture with target cells as indicated were shown.; a) normal breast-like MCF10A cells, b) luminal type BC MCF-7 cells, and c) TNBC MDA-MB-231 cells. Results were summarized from 3 independent experiments. T lymphocytes activated by SmartDC-FRα preferentially lysed FRα-expressing BC cells but exhibited low lysis of FRα-negative MCF10A cells at the indicated effector to target (E:T) ratio. (ns indicates not statistically significant, * indicates statistically significant with P-value <0.05, ** indicates statistically significant with P-value <0.01).
    Human Breast Cancer Bc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+cancer+bc+cell+lines+mda+mb+231/MDA-MB-231/pmc09342379-40-0-21
    Average 99 stars, based on 1 article reviews
    human breast cancer bc cell lines - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    human breast cancer bc cell lines mda mb231  (ATCC)
    99
    ATCC human breast cancer bc cell lines mda mb231
    Cytotoxic function of T lymphocytes activated by SmartDC-FRα against cultured BC <t>cell</t> <t>lines</t> examined by luciferase-based assay. Expression of FRα protein in normal <t>breast-like</t> (MCF10A) and breast <t>cancer</t> (MCF-7 and MDA-MB-231) target cell lines examined by immunofluorescence staining with specific anti-FRα antibody were also depicted. Expression FRα protein indicated in green. Nuclei of the cells were stained blue color. Scale bars represent 10 µm. Percentages of specific target cell lyses of unactivated T lymphocytes (white bar), T lymphocytes activated by SmartDC-iRFP (gray bar), and T lymphocytes activated by SmartDC-FRα (black bar) after co-culture with target cells as indicated were shown.; a) normal breast-like MCF10A cells, b) luminal type BC MCF-7 cells, and c) TNBC MDA-MB-231 cells. Results were summarized from 3 independent experiments. T lymphocytes activated by SmartDC-FRα preferentially lysed FRα-expressing BC cells but exhibited low lysis of FRα-negative MCF10A cells at the indicated effector to target (E:T) ratio. (ns indicates not statistically significant, * indicates statistically significant with P-value <0.05, ** indicates statistically significant with P-value <0.01).
    Human Breast Cancer Bc Cell Lines Mda Mb231, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+cancer+bc+cell+lines+mda+mb+231/MDA-MB-231/ppr0470310-47-10-32
    Average 99 stars, based on 1 article reviews
    human breast cancer bc cell lines mda mb231 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Cytotoxic function of T lymphocytes activated by SmartDC-FRα against cultured BC cell lines examined by luciferase-based assay. Expression of FRα protein in normal breast-like (MCF10A) and breast cancer (MCF-7 and MDA-MB-231) target cell lines examined by immunofluorescence staining with specific anti-FRα antibody were also depicted. Expression FRα protein indicated in green. Nuclei of the cells were stained blue color. Scale bars represent 10 µm. Percentages of specific target cell lyses of unactivated T lymphocytes (white bar), T lymphocytes activated by SmartDC-iRFP (gray bar), and T lymphocytes activated by SmartDC-FRα (black bar) after co-culture with target cells as indicated were shown.; a) normal breast-like MCF10A cells, b) luminal type BC MCF-7 cells, and c) TNBC MDA-MB-231 cells. Results were summarized from 3 independent experiments. T lymphocytes activated by SmartDC-FRα preferentially lysed FRα-expressing BC cells but exhibited low lysis of FRα-negative MCF10A cells at the indicated effector to target (E:T) ratio. (ns indicates not statistically significant, * indicates statistically significant with P-value <0.05, ** indicates statistically significant with P-value <0.01).

    Journal: Bioengineered

    Article Title: Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein

    doi: 10.1080/21655979.2022.2084262

    Figure Lengend Snippet: Cytotoxic function of T lymphocytes activated by SmartDC-FRα against cultured BC cell lines examined by luciferase-based assay. Expression of FRα protein in normal breast-like (MCF10A) and breast cancer (MCF-7 and MDA-MB-231) target cell lines examined by immunofluorescence staining with specific anti-FRα antibody were also depicted. Expression FRα protein indicated in green. Nuclei of the cells were stained blue color. Scale bars represent 10 µm. Percentages of specific target cell lyses of unactivated T lymphocytes (white bar), T lymphocytes activated by SmartDC-iRFP (gray bar), and T lymphocytes activated by SmartDC-FRα (black bar) after co-culture with target cells as indicated were shown.; a) normal breast-like MCF10A cells, b) luminal type BC MCF-7 cells, and c) TNBC MDA-MB-231 cells. Results were summarized from 3 independent experiments. T lymphocytes activated by SmartDC-FRα preferentially lysed FRα-expressing BC cells but exhibited low lysis of FRα-negative MCF10A cells at the indicated effector to target (E:T) ratio. (ns indicates not statistically significant, * indicates statistically significant with P-value <0.05, ** indicates statistically significant with P-value <0.01).

    Article Snippet: Human breast cancer (BC) cell lines (MCF-7; RRID:CVCL_0031 and MDA-MB-231; RRID:CVCL_0062) and human non-tumorigenic breast cell line (MCF10A; RRID:CVCL_0598) were from ATCC (Manassas, VA, USA).

    Techniques: Cell Culture, Luciferase, Expressing, Immunofluorescence, Staining, Co-Culture Assay, Lysis